Fundraising Fox

Waypoint Bio

6 known investors

waypointbio.com ↗

Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.

AI & Machine LearningBiotechDeep Techin /waypoint-bio@waypointbio

Founders & leadership

XW
Xinchen Wang, Ph.D.Co-founder & CEO
DP
David Phizicky, Ph.D.Co-founder & CSO

Investors · 6

Amplify PartnersMenlo Park · $500K – $5M
Fifty YearsSan Francisco · $250K – $2M
Hummingbird VenturesBelgium · $500K – $10M
Recode VenturesSan Francisco
General CatalystreportedSan Francisco · $30M – $30M
Lux CapitalreportedNew York · $100K – $100M

In the news